Carisma Therapeutics Inc. – Plans of Reorganization, Merger, Acquisition or Similar

OTC: CARM
Share price (3/27/26): $0.03
Market cap (3/27/26): $1.381 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 112 pages Agreement and Plan of Merger by and Among Carisma Therapeutics Inc., Azalea Merger Sub, Inc., Orthocellix, Inc. and Ocugen, Inc. Dated as of June 22, 2025

from 425 112 pages Agreement and Plan of Merger by and Among Carisma Therapeutics Inc., Azalea Merger Sub, Inc., Orthocellix, Inc. and Ocugen, Inc. Dated as of June 22, 2025

from 8-K 25 pages Second Amendment to Agreement and Plan of Merger and Reorganization

from 425 25 pages Plan of reorganization, merger, acquisition or similar

from 8-K 25 pages Plan of reorganization, merger, acquisition or similar

from 425 116 pages Agreement and Plan of Merger and Reorganization

from 8-K 116 pages Agreement and Plan of Merger and Reorganization

from 8-K 84 pages Share Purchase Agreement by and Among Eleven Biotherapeutics, Inc., Viventia Bio Inc., the Shareholders of Viventia Bio Inc. (Named Herein) and Solely in Its Capacity as Seller Representative, Clairmark Investments Ltd. Dated as of September 20, 2016 This Document Is Not Intended to Create Nor Will It Be Deemed to Create a Legally Binding or Enforceable Offer, Acceptance of an Offer or Agreement of Any Type or Nature, Unless and Until Agreed to and Executed by All Parties